Dr. Chun-Ka Wong is a resident cardiologist at Queen Mary Hospital and The University of Hong Kong in Hong Kong. He obtained his medical degree from The University of Hong Kong in 2015. In addition to pursuing interventional cardiology in Queen Mary Hospital, he has also been actively engaged in clinical and basic science research. His research interests include atrial fibrillation and cardiovascular inflammation and virology. His research is featured in influential peer reviewed journals, and he has received awards including Best Abstract Award from the annual American Heart Association Scientific Session. Having extensive prior experience in stem cell science, Dr. Wong and his colleagues were one of the earliest teams to utilize induced pluripotent stem cell-derived cardiomyocytes as an in-vitro platform for recapitulating myocardial damage related to Coronavirus Disease 2019 (COVID-19) and drug screening.